Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-020488
Filing Date
2021-03-15
Accepted
2021-03-15 16:50:39
Documents
1
Period of Report
2021-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3115
  Complete submission text file 0001209191-21-020488.txt   4475
Mailing Address 64 MONTAUK AVENUE STONINGTON CT 06378
Business Address
Hutson Nancy J (Reporting) CIK: 0001379222 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 21742123

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations